Data on the stability of darunavir/cobicistat suspension after tablet manipulation

The COVID-19 outbreak is now one of the most critical crises to manage for most of the national healthcare systems in the world. In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combination, are used off-label in the hospital wards a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanon, D., Manca, A., De Nicolò, A., D'Avolio, A., Musazzi, U.M., Cilurzo, F., Maximova, N., Tomasello, C., Minghetti, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Pharmacology, Toxicology and Pharmaceutical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152873/
https://www.ncbi.nlm.nih.gov/pubmed/32292805
http://dx.doi.org/10.1016/j.dib.2020.105552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152873/
https://www.ncbi.nlm.nih.gov/pubmed/32292805
http://dx.doi.org/10.1016/j.dib.2020.105552

Ejemplares similares